Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Device-based Rate Versus Rhythm Control Treatment in Patients With Symptomatic Recent-onset Atrial Fibrillation in the Emergency Department (RACE 9 OBSERVE-AF)

NCT04612335 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT04612335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Device-based Rate Versus Rhythm Control Treatment in Patients With Symptomatic Recent-onset Atrial Fibrillation in the Emergency Department (RACE 9 OBSERVE-AF)
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
November 16, 2020
Completion date
June 30, 2025
Enrollment
490 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation